Holen Sie sich die Stockscreener-App
0.28
2.23%
0.0061
Handel nachbörslich:
.27
-0.01
-3.57%
Schlusskurs vom Vortag:
$0.2739
Offen:
$0.28
24-Stunden-Volumen:
505.12K
Relative Volume:
0.08
Marktkapitalisierung:
$7.97M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-0.3457
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
-3.38%
1M Leistung:
-8.74%
6M Leistung:
-65.00%
1J Leistung:
-83.72%
1-Tages-Spanne:
$0.26
$0.2819
1-Wochen-Bereich:
$0.26
$0.2971
52-Wochen-Spanne:
$0.1639
$2.2592
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.28 | 7.80M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
bioAffinity Technologies Sees Surge in CyPath® Lung Test Sales - TipRanks
BioAffinity Technologies Raises $1.2 Million in Private Placement - MarketScreener
bioAffinity Technologies raises $1.2 million in private placement - Investing.com
bioAffinity Secures Fresh Capital as Investors Back Early-Stage Cancer Detection Technology - Stock Titan
Navigating Dilution and Growth: bioAffinity Technologies' Warrant Strategy in the Biotech Landscape - AInvest
BioAffinity Technologies Announces $1.2M Capital Raise Through Private Placement Of 990 Series B Preferred Shares Convertible Into 4.3M Common Shares At $0.23/Share And 6.7M Warrants At $0.352/Share, Plus $253K Warrant Inducement For Immediat - 富途牛牛
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds - Yahoo Finance
D-Wave Quantum vs. IonQ: Which is the Better Quantum Computing Stock? - The Globe and Mail
AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun - The Globe and Mail
Can bioAffinity Technologies Inc. Equity Warrant maintain its current growth rateLow Price High Return Opportunities - mustnews.co.kr
The Smartest Growth Stock to Buy With $1,000 Right Now - The Globe and Mail
Can bioAffinity Technologies Inc. be recession proofSuper Growth Stock Predictions - sisaissue.com
Veradigm Inc. Delays Q2 2025 Financial Report - The Globe and Mail
Akamai Q2 Earnings Surpass Estimates, Revenues Increase Y/Y - The Globe and Mail
Published on: 2025-08-08 17:01:07 - beatles.ru
BIG ROCK BREWERY INC. ANNOUNCES SECOND QUARTER 2025 RESULTS AND A 45% INCREASE IN SECOND QUARTER SALES VOLUMES - The Globe and Mail
Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer - The Globe and Mail
Published on: 2025-08-04 09:31:00 - beatles.ru
What are bioAffinity Technologies Inc. Equity Warrant company’s key revenue driversGet high-impact stock recommendations now - Jammu Links News
How strong is bioAffinity Technologies Inc. Equity Warrant company’s balance sheetMarket-crushing profits - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. Equity Warrant stockCapitalize on strategic market trends - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a growth stock or a value stockAchieve rapid wealth accumulation through smart investing - Jammu Links News
bioAffinity Technologies Inc. Stock Analysis and ForecastAchieve rapid financial growth with expert picks - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant stock overvalued or undervaluedFree Market Dynamics Reports - Jammu Links News
How volatile is bioAffinity Technologies Inc. stock compared to the marketFree Market Dynamics Reports - Jammu Links News
What analysts say about bioAffinity Technologies Inc. stockFree Predictions - Jammu Links News
What makes bioAffinity Technologies Inc. stock price move sharplyUnlock powerful insights from market experts - Jammu Links News
What catalysts could drive bioAffinity Technologies Inc. Equity Warrant stock higher in 2025Tremendous growth opportunities - Jammu Links News
Published on: 2025-08-03 18:51:54 - Jammu Links News
How does bioAffinity Technologies Inc. Equity Warrant compare to its industry peersBuild a winning investment strategy - Jammu Links News
What are bioAffinity Technologies Inc. company’s key revenue driversPhenomenal capital appreciation - Jammu Links News
Should I hold or sell bioAffinity Technologies Inc. Equity Warrant stock in 2025Achieve breakthrough investment performance - Jammu Links News
Why is bioAffinity Technologies Inc. Equity Warrant stock attracting strong analyst attentionUnprecedented profits - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc.Discover the fastest growing stocks today - Jammu Links News
What are the latest earnings results for bioAffinity Technologies Inc. Equity WarrantNavigate market shifts with confidence - Jammu Links News
What is the dividend policy of bioAffinity Technologies Inc. stockLightning-fast growth - Jammu Links News
Is bioAffinity Technologies Inc. Equity Warrant a good long term investmentMarket-crushing profits - Jammu Links News
Why is bioAffinity Technologies Inc. stock attracting strong analyst attentionCapitalize on emerging trends for profits - Jammu Links News
bioAffinity’s CyPath® Lung Test Detects Early Cancer - MSN
Price Consolidation Hints at Upcoming Move in bioAffinity Technologies Inc. Equity WarrantIntraday Trend Analysis for Fast Gains Released - metal.it
bioAffinity Technologies' CyPath Lung Test Detects Early Cancer with High Accuracy - AInvest
What is bioAffinity Technologies Inc. Equity Warrant company’s growth strategySwing Trade Growth Plan With High Returns - Jammu Links News
Annaly Capital to Issue Series J Preferred; Redeemable 2030 | BIAFW SEC FilingForm 8-K - Stock Titan
Building trade automation scripts for bioAffinity Technologies Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
How Resilient Is bioAffinity Technologies Inc. Stock During Economic DownturnsWeekly Stock Opportunity Radar Scanner Activated - metal.it
Revolutionary CyPath Lung Test Catches Hidden Cancer After Standard Tests Failed: Critical Case Study Reveals - Stock Titan
Published on: 2025-07-28 23:30:16 - metal.it
bioAffinity Technologies Inc. Pullback Analyzed — Is It Time to ExitCommunity Entry Consensus Trade Ideas Shared - metal.it
How many analysts rate bioAffinity Technologies Inc. Equity Warrant as a “Buy”Identify winners with top-tier analysis - Jammu Links News
Technical Models Detect Momentum Build in bioAffinity Technologies Inc. Equity WarrantTarget Return Focused Trade Insights Shared - metal.it
Is bioAffinity Technologies Inc. stock entering bullish territory Free Smart Trend Trading with Weekly Signals - metal.it
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):